Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04964726 · ClinicalTrials.gov registry record · NA
Dyadic Neurofeedback for Emotion Regulation in Youth With Maternal Adversity
A NA study, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04964726: Completed NA study, sponsored by Oklahoma State University Center for Health Sciences.
NCT04964726 is a NA study that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04964726, a NA study, has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.
Primary Outcome
Activation in the brain region targeted for neurofeedback and associated regions at Session 1. We hypothesize that lower activity will indicate a better outcome.
Interventions
- BEHAVIORAL Real-time fMRI dyadic neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-11 |
| Est. Completion | 2022-12-07 |
| Phase | NA |
What the finished NCT04964726 record still lists
NCT04964726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Real-time fMRI dyadic neurofeedback is the first listed.
NCT04964726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04964726 about?
NCT04964726 is a clinical study titled "Dyadic Neurofeedback for Emotion Regulation in Youth With Maternal Adversity". This study will examine the effect of a real-time functional magnetic resonance imaging (fMRI) dyadic neurofeedback protocol with mothers and their adolescent daughters. Mothers will view a moving bar showing their daughters' brain activity on a computer screen while talking to their daughters.
What is the current status of trial NCT04964726?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-11. Estimated completion is 2022-12-07.
What interventions are being tested in trial NCT04964726?
The interventions under investigation include: Real-time fMRI dyadic neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT04964726?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04964726's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI